Sinphar Pharmaceutical Co Ltd (1734)

Taiwan

Currency in TWD

31.55

+0.10(+0.32%)

Closed·25/07

Fair Value

Unlock Value

Day's Range

31.45

31.60

52 wk Range

27.25

38.50

1734 Financial Summary

A brief financial summary of Sinphar Pharmaceutical Co Ltd as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio19.41

Price/Book1.75

Debt / Equity49.29%

Return on Equity8.05%

Dividend Yield3.17%

EBITDA539.99M

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

2,388.45

2,433.52

2,856.65

2,962.93

3,150.63

Gross Profit

aa.aa

875.53

888.71

1,092.59

1,093.93

1,240.31

Operating Income

aa.aa

-122.2

-182.77

198.63

288.74

297.16

Net Income

aa.aa

-28.51

-38.14

224.64

375.17

304.71

Balance Sheet

Total Assets

aa.aa

6,126.92

6,220.93

6,185.19

6,251.08

6,298.26

Total Current Liabilities

aa.aa

1,329.9

1,534.5

1,445.91

1,204.69

1,422.81

Total Equity

aa.aa

3,143.82

3,077.18

3,216.85

3,397.87

3,546.18

Cash Flow

Levered Free Cash Flow

aa.aa

88.23

65.95

206.61

-125.83

232.08

Cash from Operations

aa.aa

146.39

135.54

425.3

296.37

593.51

Cash from Investing

aa.aa

-165.68

-205.6

-124.24

-334.56

-391.08

Cash from Financing

aa.aa

318.73

122.95

-263.33

-120.67

-209.08

Net Change in Cash

aa.aa

303.05

51.02

42.77

-163.07

1.18

* In Millions of TWD (except for per share items)

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS 1.69%

Dividend Yield

3.17%

Industry Median 2.53%

Annualised payout

1.00

Paid annually

5-Years Growth

+40.11%

Growth Streak

Unlock

Earnings

Latest Release

May 15, 2025

EPS / Forecast

0.62 / 0.43

Revenue / Forecast

805.59M / 816.00M

EPS Revisions

Unlock

Last 90 days

FAQ

What were Sinphar's earnings for the latest quarter?

The Sinphar EPS (TTM) is 1.69. Sinphar reported sales of 805.59, net income of 112.39, and EPS of 0.62 for the latest quarter.

What was Sinphar's net income for the latest quarter?

Sinphar's net income for the latest quarter was 112.39.

How did Sinphar's performance compare year-over-year in the latest quarter?

The company's revenue moved from 854.39 in the previous quarter to 805.59 in the latest quarter, and net income moved from 81.77 to 112.39 compared to the previous quarter.

What is Sinphar's net profit margin on a TTM basis?

Sinphar's trailing twelve months (TTM) net profit margin is 9.67%.

How does Sinphar's debt to equity ratio compare to industry standards?

Sinphar's total debt-to-equity ratio is 49.29%.

What is Sinphar's return on investment on a TTM basis?

Sinphar's trailing twelve months (TTM) return on investment (ROI) is 8.05%.

Did Sinphar gain or lose cash last quarter?

In the latest quarter, Sinphar's net change in cash was -112.55 million.

What were Sinphar's total assets and liabilities in the latest quarter?

As of the latest quarter, Sinphar reported total assets of 6,315.33 million and total liabilities of 1,043.10 million.

How has Sinphar's total revenue grown this year?

Sinphar's total revenue was 854.39 in the previous quarter and 805.59 in the latest quarter.

What is Sinphar's gross margin on a TTM basis?

Sinphar's trailing twelve months (TTM) gross margin is 39.87%.

What was Sinphar's revenue per share for the latest quarter?

Sinphar's revenue per share for the latest quarter was 22.93.

NSE 30

4,932.39

+44.05

+0.90%

NSE All Share

134,452.94

+1,252.96

+0.94%

US 30

44,899.80

+205.7

+0.46%

US 500

6,393.40

+30.0

+0.47%

FTSE 100

9,120.31

-18.06

-0.20%

DAX

24,217.50

-78.43

-0.32%

South Africa Top 40

91,303.40

-954.88

-1.04%

Market Movers

Name	Last	Chg. %	Vol.
Access Holdings	27.70	-2.81%	42.42M
Guaranty Trust Holding	94.00	-0.11%	28.71M
Zenith Bank	74.00	+1.09%	16.96M
MTN Nigeria	400.00	+1.27%	3.44M
Okomu Oil Palm	998.00	+5.05%	2.58M
Presco	1,550.00	+7.68%	900.61K
Seplat Petroleum	5,450.00	0.00%	337.85K

Name	Last	Chg. %	Vol.
Champion Brew	12.32	+10.00%	1.69M
Unilever Nigeria	68.20	+10.00%	1.19M
Ikeja	23.100	+10.00%	3.01M
Nigerian Enamelware PLC	27.00	+9.98%	110.03K
Initiates	16.13	+9.95%	3.53M
Academy Press	9.31	+9.92%	2.12M
Prestige	1.23	+9.82%	13.85M

Name	Last	Chg. %	Vol.
Tripple Gee and Co	3.51	-10.00%	469.29K
Tantalizers	2.46	-8.55%	32.20M
Sunu Assurances	4.64	-6.64%	18.84M
ETI	32.00	-5.88%	4.55M
Neimeth	6.50	-4.55%	7.07M
Rtbriscoe	3.58	-4.53%	5.90M
Linkassure	1.50	-3.23%	894.80K

Trending Stocks

Name	Last	Chg. %	Vol.
Ellah Lakes	9.80	-2.00%	26.34M
Access Holdings	27.70	-2.81%	42.42M
Champion Brew	12.32	+10.00%	1.69M
BUA Cement	135.00	0.00%	1.01M
MTN Nigeria	400.00	+1.27%	3.44M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaaaaa Aaaaaaa	5,450.00	+29.88%	7,078.46
A Aaaaaaaaaaa	66.50	+28.33%	85.34
Aaaa Aaaaaaaaaa Aa	493.00	+25.21%	617.29
Aaaaaaaaaaaaaaaa	400.00	+10.33%	441.32

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Sinphar Pharmaceutical Co Ltd (1734)

1734 Financial Summary

Key Ratios

Statements Highlights

Dividends

Earnings

FAQ

What were Sinphar's earnings for the latest quarter?

What was Sinphar's net income for the latest quarter?

How did Sinphar's performance compare year-over-year in the latest quarter?

What is Sinphar's net profit margin on a TTM basis?

How does Sinphar's debt to equity ratio compare to industry standards?

What is Sinphar's return on investment on a TTM basis?

Did Sinphar gain or lose cash last quarter?

What were Sinphar's total assets and liabilities in the latest quarter?

How has Sinphar's total revenue grown this year?

What is Sinphar's gross margin on a TTM basis?

What was Sinphar's revenue per share for the latest quarter?

Trending Stocks